Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
12MO Patterns of response in metastatic (m) NSCLC after 2 and 4 cycles of chemotherapy (CT), alone or with durvalumab (D) ± tremelimumab (T), in the phase III POSEIDON studyReinmuth, N. ; Cho, B.C. ; Luft, A. ; Alexander, J.A. Alatorre ; Geater, S. Lucien ; Laktionov, K. ; Kim, S-W. ; Ursol, G. ; Hussein, M. ; Lim, F.L. ; Yang, C-T. ; Araujo, L.H. ; Saito, H. ; Barrett, K. ; Lowery, C. ; Tattersfield, R. ; Peters, S. ; Garon, E.B. ; Mok, T.S.K. ; Johnson, M.L.Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S44-S46 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
1736O - IMpower133: Updated overall survival (OS) analysis of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC)Reck, M. ; Liu, S.V. ; Mansfield, A.S. ; Mok, T.S.K. ; Scherpereel, A. ; Reinmuth, N. ; Garassino, M.C. ; De Carpeno, JCastro ; Califano, R. ; Nishio, M. ; Orlandi, F. ; Alexander, J A Alatorre ; Leal, T.A. ; Cheng, Y. ; Lee, J.-S. ; Lam, S. ; McCleland, M. ; Deng, Y. ; Phan, S. ; Horn, L.Annals of oncology, 2019-10, Vol.30, p.v710-v711 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
1736OIMpower133: Updated overall survival (OS) analysis of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC)Reck, M ; Liu, S V ; Mansfield, A S ; Mok, T S K ; Scherpereel, A ; Reinmuth, N ; Garassino, M C ; Carpeno, J De Castro ; Califano, R ; Nishio, M ; Orlandi, F ; Alexander, J A Alatorre ; Leal, T A ; Cheng, Y ; Lee, J-S ; Lam, S ; McCleland, M ; Deng, Y ; Phan, S ; Horn, LAnnals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
|
4 |
Material Type: Artigo
|
326P Durvalumab (D) ± tremelimumab (T) + chemotherapy (CT) in 1L metastatic (m) NSCLC: Overall survival (OS) update from POSEIDON after median follow-up (mFU) of approximately 4 years (y)Cho, B.C. ; Luft, A. ; Alatorre Alexander, J.A. ; Lucien Geater, S. ; Laktionov, K. ; Sang-We, K. ; Ursol, G. ; Hussein, M. ; Lim Farah, L. ; Yang, C.T. ; Araujo, L.H. ; Saito, H. ; Reinmuth, N. ; Lai, Z. ; Mann, H. ; Shi, X. ; Peters, S. ; Garon, E.B. ; Mok, T.S.K. ; Johnson, M.L.Annals of oncology, 2022-11, Vol.33, p.S1569-S1570 [Periódico revisado por pares]Texto completo disponível |
|
5 |
Material Type: Artigo
|
5MO Patient reported outcomes (PROs) with 1L durvalumab (D), with or without tremelimumab (T), plus chemotherapy (CT) in metastatic (m) NSCLC: Results from POSEIDONGaron, E.B. ; Cho, B.C. ; Luft, A. ; Alatorre-Alexander, J. ; Geater, S.L. ; Trukhin, D. ; Kim, S-W. ; Ursol, G. ; Hussein, M. ; Lim, F.L. ; Yang, C-T. ; Araujo, L.H. ; Saito, H. ; Reinmuth, N. ; Medic, N. ; Mann, H. ; Shi, X. ; Peters, S. ; Mok, T.S.K. ; Johnson, M.Annals of oncology, 2022-04, Vol.33, p.S29-S30 [Periódico revisado por pares]Texto completo disponível |
|
6 |
Material Type: Artigo
|
9P Final results from TAIL: Updated long-term safety and efficacy of atezolizumab (atezo) in a diverse population of patients (pts) with previously treated advanced NSCLCArdizzoni, A. ; Azevedo, S. ; Rubio-Viqueira, B. ; Rodriguez-Abreu, D. ; Alatorre-Alexander, J. ; Smit, H.J.M. ; Yu, J. ; Syrigos, K. ; Hoglander, E. ; Kaul, M. ; Tolson, J. ; Hu, Y. ; Vollan, H.K. ; Newsom-Davis, T.Annals of oncology, 2022-04, Vol.33, p.S32 [Periódico revisado por pares]Texto completo disponível |
|
7 |
Material Type: Artigo
|
Acondrogénesis tipo 1A1 recurrente debida a una variante alélica del gen COL10A1?Ramírez-García, Sergio Alberto ; García-Cruz, Diana ; Bitar-Alatorre, Wadih Emilio ; Baltazar-Rodríguez, Luz Margarita ; Montaño-Montejano, Claudia B. ; Sánchez-Corona, JoséCirugia y cirujanos, 2019-09, Vol.87 (5) [Periódico revisado por pares]Texto completo disponível |
|
8 |
Material Type: Artigo
|
Adhérence et persistance observées plus élevées chez des patients avec un diabète de type 2 traités avec dulaglutide, par comparaison à l’exénatide en une prise hebdomadaire, ou au liraglutideLandó, Laura Fernández ; Alatorre, Carlos ; Brown, Katelyn ; Mody, Reema ; Montejano, Leslie ; Juneau, Paul ; Huang, Alice ; Yu, MariaDiabetes & metabolism, 2017-03, Vol.43 (2), p.A107-A108 [Periódico revisado por pares]Texto completo disponível |
|
9 |
Material Type: Artigo
|
Analyzing pelagic food webs leading to top predators in the Pacific Ocean: A graph-theoretic approachDambacher, Jeffrey M. ; Young, Jock W. ; Olson, Robert J. ; Allain, Valérie ; Galván-Magaña, Felipe ; Lansdell, Matthew J. ; Bocanegra-Castillo, Noemí ; Alatorre-Ramírez, Vanessa ; Cooper, Scott P. ; Duffy, Leanne M.Progress in oceanography, 2010-07, Vol.86 (1-2), p.152-165 [Periódico revisado por pares]Texto completo disponível |
|
10 |
Material Type: Artigo
|
Application of electrochemical/BDD process for the treatment wastewater effluents containing pharmaceutical compoundsGarcía-Montoya, M. Fernanda ; Gutiérrez-Granados, Silvia ; Alatorre-Ordaz, Alejandro ; Galindo, R. ; Ornelas, Rubén ; Peralta-Hernández, Juan M.Journal of Industrial and Engineering Chemistry, 2015, 31(0), , pp.238-243 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |